| Title |
Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II)
|
|---|---|
| Published in |
Journal of Neuro-Oncology, August 2019
|
| DOI | 10.1007/s11060-019-03227-7 |
| Pubmed ID | |
| Authors |
John D. Hainsworth, Kevin P. Becker, Tarek Mekhail, Sajeel A. Chowdhary, Janice Faulkner Eakle, David Wright, Robert M. Langdon, Kathleen J. Yost, Gilbert Darin Anthony Padula, Kimberly West-Osterfield, Meredith Scarberry, Candice A. Shaifer, Mythili Shastry, Howard A. Burris, Kent Shih |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Portugal | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 31 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 6 | 19% |
| Other | 2 | 6% |
| Student > Bachelor | 2 | 6% |
| Lecturer | 2 | 6% |
| Student > Ph. D. Student | 2 | 6% |
| Other | 1 | 3% |
| Unknown | 16 | 52% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 6 | 19% |
| Nursing and Health Professions | 2 | 6% |
| Psychology | 2 | 6% |
| Neuroscience | 2 | 6% |
| Sports and Recreations | 1 | 3% |
| Other | 1 | 3% |
| Unknown | 17 | 55% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 August 2019.
All research outputs
#20,576,667
of 23,153,849 outputs
Outputs from Journal of Neuro-Oncology
#2,597
of 2,997 outputs
Outputs of similar age
#293,387
of 345,121 outputs
Outputs of similar age from Journal of Neuro-Oncology
#63
of 67 outputs
Altmetric has tracked 23,153,849 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,997 research outputs from this source. They receive a mean Attention Score of 4.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,121 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.